...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers

Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers

posted on Nov 02, 2020 12:50PM

jonzobot - NAFLD. Is that the next domino?

RVX put out a call for partners for the testing of apabetalone with COVID in May-ish. They have a presentation at the AHA that is directly speaking about COVID. Sounds like COVID could be the next domino. That should also answer 10-41's query about COVID testing and ABL as well. Maybe there will be a PR about it prior to the start of their AHA presentation. Heck it would sure be nice to hear about a partnership at the AHA.

tada

Share
New Message
Please login to post a reply